| Literature DB >> 33162812 |
Ke Tang1, Jianxiao Li1, Tianji Huang1, Weiyang Zhong1, Xiaoji Luo1, Zhengxue Quan1.
Abstract
A retrospective study investigated and compared the results of lamina with spinous process (LSP), transverse process strut (TPS) and iliac graft (IG) as bone graft in thoracic single-segment spinal tuberculosis(TB) with the one-stage posterior approach of debridement, fusion and internal instrumentation. 99 patients treated from January 2012 to December 2015 were reviewed. LSP was performed in 35 patients (group A), TPS was undertaken in 33 patients (group B), and IG was carried out in 31 patients (group C). Surgical time, blood loss, hospitalization time, drainage volume, and follow-up (FU) duration were recorded. The visual analog scale (VAS), Oswestry Disability Index (ODI), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), American Spinal Injury Association (ASIA) grade, segmental angle, intervertebral height and bone fusion time were compared between preoperative and final FU. All the patients were followed up for a mean 43.90±10.39 months in group A, 45.30±6.20 months in group B, 44.32±7.17 months in group C without difference(P>0.05). The mean age was younger, the blood loss was less, the hospitalization time and the surgical time were shorter in group A than those in group B and C (P<0.05). The drainage volume was less in group A than that in group B and group C. The CRP, ESR, VAS, and ODI were significantly decreased and there were no significant difference among the groups at the final FU. The neurological function after surgery was improved compared with preoperation among the groups. The bony fusion at a mean time 12.90±3.91 months in group A was longer than that in group B (6.75±1.55 months) and group C (5.52±1.64 months) (P<0.05). No significant difference was found at the mean segmental angle, mean intervetebral height of preoperation and final FU among the groups (P>0.05). In conclusion, the LSP and TPS as bone graft are reliable, safe, and effective for single-segment stability reconstruction for surgical management of thoracic TB and TPS could be new bone graft methods. © The author(s).Entities:
Keywords: bone graft; lamina; spinous process; thoracic spine; transverse process strut; tuberculosis
Mesh:
Substances:
Year: 2020 PMID: 33162812 PMCID: PMC7645334 DOI: 10.7150/ijms.47309
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Information of patients
| Group A | Group B | Group C | PAB | PAC | PBC | |
|---|---|---|---|---|---|---|
| No. of patients (n) | 35 | 33 | 31 | |||
| Male/female (n) | 19/16 | 21/12 | 15/16 | |||
| Mean age (years) | 33.65±11.06 | 47.13±18.10 | 41.48±13.99 | <0.0001 | <0.0001 | 0.7619 |
| Hospital stay (days) | 14.05±3.58 | 17.61±5.03 | 17.88±10.06 | <0.0001 | <0.0001 | 0.9168 |
| Surgery time (minutes) | 182.40±23.82 | 205.10±25.60 | 231.40±80.90 | 0.6327 | <0.0001 | <0.0001 |
| Blood loss (ml) | 280.80±76.82 | 301.50±165.40 | 510.00±300.00 | 0.8305 | <0.0001 | <0.0001 |
| Drainage (ml) | 340.00±167.20 | 450.55±171.80 | 620.90±150.65 | 0.0176 | 0.0192 | 0.0444 |
| Mean fusion time (months) | 12.90±3.91 | 6.75±1.55 | 5.52±1.64 | <0.0001 | <0.0001 | 0.3465 |
| Follow-up (months) | 43.90 ± 10.39 | 45.30±6.20 | 44.32±7.17 | 0.1530 | 0.1760 | 0.9529 |
Clinical and radiographic outcomes
| Parameter | Group A | Group B | Group C | PAB | PAC | PBC |
|---|---|---|---|---|---|---|
| before treatment | 79.75±7.55 | 62.51±17.45 | 63.72±15.61 | 0.0126 | 0.0147 | 0.8867 |
| Final FU | 13.95±4.50 | 10.61±2.96 | 13.36 ±3.13 | 0.3044 | 0.9896 | 0.4096 |
| before treatment | 6.95±0.94 | 6.5±0.75 | 6.68±1.25 | 0.8702 | 0.7670 | 0.8023 |
| Final FU | 1.95±0.69 | 1.58±0.95 | 1.68±0.76 | 0.8296 | 0.8888 | 0.9607 |
| before treatment | 39.95±4.84 | 40.25±4.12 | 40.76±4.74 | 0.7247 | 0.7019 | 0.9400 |
| Final FU | 4.50±1.54 | 4.56±1.33 | 4.88±1.11 | 0.9417 | 0.9296 | 0.7670 |
| before treatment | 17.97±2.80 | 18.77±2.49 | 24.61±14.96 | 0.6452 | 0.1638 | 0.5004 |
| Final FU | 16.25±3.64 | 15.01±3.55 | 17.62±5.38 | 0.7643 | 0.8090 | 0.7289 |
| before treatment | 11.30±1.80 | 11.70±1.90 | 12.19±1.92 | 0.1377 | 0.1377 | 0.1962 |
| Final FU | 10.30±1.25 | 10.60±1.50 | 11.99±1.17 | 0.3329 | 0.1639 | 0.9010 |
ODI: Oswestry Disability Index; VAS: visual analog scale; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; FU: follow-up.